Andhra Pradesh latest news : AP Medtech Zone (AMTZ) in Visakhapatnam has achieved another level. Along with its partner Transasia Diagnostics Pvt Ltd has produced an RT-PCR kit for the diagnosis of Empox (Monkeypox).
ErbaMDX has developed a kit called Monkeypox RT-PCR. It was announced on Saturday that this is the first indigenously designed testing kit for the diagnosis of Empox. It has been approved by the Indian Council for Medical Research (ICMR) and has been granted emergency clearances from the Central Drug Standard Control Organization under the Union Ministry of Health and Family Welfare. Dr. Jitendra Sharma, CEO of Medtech Zone stated that this reflects the fact that India is at the forefront of global health innovation.
This is the proof of India’s talent in the field of health. It will be available in the markets in two weeks, he said. Medtech Zone has made many important innovations in the healthcare sector during the Covid disaster. One million RTPCR kits, 500 oxygen concentrators and 100 ventilators are manufactured here per day.